• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

动脉瘤性蛛网膜下腔出血后的迟发性脑缺血:补体和固有免疫系统的作用

Delayed Cerebral Ischemia After Aneurysmal Subarachnoid Hemorrhage: The Role of the Complement and Innate Immune System.

作者信息

Provencio Jose Javier, Inkelas Sonya, Vergouwen Mervyn D I

机构信息

Department of Neurology, University of Virginia, Charlottesville, VA, USA.

Department of Neurology and Neurosurgery, UMC Utrecht Brain Center, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.

出版信息

Transl Stroke Res. 2025 Feb;16(1):18-24. doi: 10.1007/s12975-024-01290-5. Epub 2024 Aug 21.

DOI:10.1007/s12975-024-01290-5
PMID:39168941
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11772402/
Abstract

Specific inflammatory pathways are important in the development of delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage. Understanding the specific pathways of inflammation may be critical for finding new treatments. Evidence is accumulating that innate inflammatory cells and proteins play a more important role than cells of the adaptive inflammatory system. In this work, we review the evidence from clinical and preclinical data regarding which cells of the immune system play a role in DCI with particular emphasis on the bone-marrow-derived cells monocytes and neutrophils and the brain parenchymal microglia. In addition, we will review the evidence that complement proteins, a non-cellular part of the innate immune system, play a role in the development of DCI.

摘要

特定的炎症通路在动脉瘤性蛛网膜下腔出血后迟发性脑缺血的发生发展中起重要作用。了解炎症的具体通路对于寻找新的治疗方法可能至关重要。越来越多的证据表明,先天性炎症细胞和蛋白质比适应性炎症系统的细胞发挥更重要的作用。在这项工作中,我们回顾了来自临床和临床前数据的证据,这些证据表明免疫系统的哪些细胞在迟发性脑缺血中起作用,特别强调骨髓来源的细胞单核细胞和中性粒细胞以及脑实质小胶质细胞。此外,我们将回顾补体蛋白(先天性免疫系统的非细胞部分)在迟发性脑缺血发生发展中起作用的证据。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3490/11772402/7ff5881ca6de/12975_2024_1290_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3490/11772402/7ff5881ca6de/12975_2024_1290_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3490/11772402/7ff5881ca6de/12975_2024_1290_Fig1_HTML.jpg

相似文献

1
Delayed Cerebral Ischemia After Aneurysmal Subarachnoid Hemorrhage: The Role of the Complement and Innate Immune System.动脉瘤性蛛网膜下腔出血后的迟发性脑缺血:补体和固有免疫系统的作用
Transl Stroke Res. 2025 Feb;16(1):18-24. doi: 10.1007/s12975-024-01290-5. Epub 2024 Aug 21.
2
Regulatory T Cell- and Natural Killer Cell-Mediated Inflammation, Cerebral Vasospasm, and Delayed Cerebral Ischemia in Aneurysmal Subarachnoid Hemorrhage-A Systematic Review and Meta-Analysis Approach.调节性T细胞和自然杀伤细胞介导的炎症、脑血管痉挛及动脉瘤性蛛网膜下腔出血中的迟发性脑缺血——一项系统评价和荟萃分析方法
Int J Mol Sci. 2025 Feb 1;26(3):1276. doi: 10.3390/ijms26031276.
3
Early and delayed blood-brain barrier permeability predicts delayed cerebral ischemia and outcomes following aneurysmal subarachnoid hemorrhage.早期和延迟的血脑屏障通透性可预测动脉瘤性蛛网膜下腔出血后的迟发性脑缺血和结局。
Eur Radiol. 2024 Aug;34(8):5287-5296. doi: 10.1007/s00330-023-10571-w. Epub 2024 Jan 15.
4
Interleukin 6 in cerebrospinal fluid is a biomarker for delayed cerebral ischemia (DCI) related infarctions after aneurysmal subarachnoid hemorrhage.脑脊髓液中的白细胞介素 6 是与蛛网膜下腔出血后迟发性脑缺血(DCI)相关梗死的生物标志物。
Sci Rep. 2021 Jan 8;11(1):12. doi: 10.1038/s41598-020-79586-3.
5
Acute impairment of saccadic eye movements is associated with delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage.急性扫视眼动障碍与动脉瘤性蛛网膜下腔出血后迟发性脑缺血有关。
J Neurosurg. 2017 Oct;127(4):754-760. doi: 10.3171/2016.8.JNS16408. Epub 2016 Dec 9.
6
The role of immune inflammation in aneurysmal subarachnoid hemorrhage.免疫炎症在颅内动脉瘤性蛛网膜下腔出血中的作用。
Exp Neurol. 2021 Feb;336:113535. doi: 10.1016/j.expneurol.2020.113535. Epub 2020 Nov 27.
7
Delayed Cerebral Ischemia After Aneurysmal Subarachnoid Hemorrhage in Patients With a History of Migraine.偏头痛病史的动脉瘤性蛛网膜下腔出血患者的迟发性脑缺血。
Stroke. 2020 Oct;51(10):3039-3044. doi: 10.1161/STROKEAHA.120.030118. Epub 2020 Sep 1.
8
Plasma Levels of IL-6, IL-8, IL-10, ICAM-1, VCAM-1, IFNγ, and TNFα are not Associated with Delayed Cerebral Ischemia, Cerebral Vasospasm, or Clinical Outcome in Patients with Subarachnoid Hemorrhage.血浆中 IL-6、IL-8、IL-10、ICAM-1、VCAM-1、IFNγ 和 TNFα 的水平与蛛网膜下腔出血患者的迟发性脑缺血、脑血管痉挛或临床转归无关。
World Neurosurg. 2019 Aug;128:e1131-e1136. doi: 10.1016/j.wneu.2019.05.102. Epub 2019 May 20.
9
Association of nosocomial infections with delayed cerebral ischemia in aneurysmal subarachnoid hemorrhage.医院获得性感染与动脉瘤性蛛网膜下腔出血后迟发性脑缺血的关系。
J Neurosurg. 2016 Dec;125(6):1383-1389. doi: 10.3171/2015.10.JNS151959. Epub 2016 Feb 12.
10
Impaired cerebrovascular reactivity may predict delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage.脑血流反应性受损可能预测动脉瘤性蛛网膜下腔出血后的迟发性脑缺血。
J Neurol Sci. 2019 Dec 15;407:116539. doi: 10.1016/j.jns.2019.116539. Epub 2019 Oct 17.

引用本文的文献

1
MiR-34c Is Predictive of Delayed Cerebral Ischemia After Subarachnoid Hemorrhage.微小RNA-34c可预测蛛网膜下腔出血后迟发性脑缺血
Res Sq. 2025 Apr 1:rs.3.rs-6198784. doi: 10.21203/rs.3.rs-6198784/v1.
2
Regulatory T Cell- and Natural Killer Cell-Mediated Inflammation, Cerebral Vasospasm, and Delayed Cerebral Ischemia in Aneurysmal Subarachnoid Hemorrhage-A Systematic Review and Meta-Analysis Approach.调节性T细胞和自然杀伤细胞介导的炎症、脑血管痉挛及动脉瘤性蛛网膜下腔出血中的迟发性脑缺血——一项系统评价和荟萃分析方法
Int J Mol Sci. 2025 Feb 1;26(3):1276. doi: 10.3390/ijms26031276.
3
Temporal Trends in Serum Homer1 Levels and Their Prognostic Implications in Aneurysmal Subarachnoid Hemorrhage: A Prospective Cohort Study.

本文引用的文献

1
Glymphatic and lymphatic communication with systemic responses during physiological and pathological conditions in the central nervous system.中枢神经系统在生理和病理条件下与全身反应的糖质和淋巴管连通。
Commun Biol. 2024 Feb 24;7(1):229. doi: 10.1038/s42003-024-05911-5.
2
Ly6C-high monocytes alleviate brain injury in experimental subarachnoid hemorrhage in mice.Ly6C-高单核细胞减轻小鼠实验性蛛网膜下腔出血后的脑损伤。
J Neuroinflammation. 2023 Nov 17;20(1):270. doi: 10.1186/s12974-023-02939-y.
3
Interleukin-4 Modulates Neuroinflammation by Inducing Phenotypic Transformation of Microglia Following Subarachnoid Hemorrhage.
动脉瘤性蛛网膜下腔出血患者血清Homer1水平的时间趋势及其预后意义:一项前瞻性队列研究
Int J Gen Med. 2025 Feb 1;18:567-584. doi: 10.2147/IJGM.S508325. eCollection 2025.
4
Transcranial Doppler Arterial Pressure Gradient Is Associated With Delayed Infarction After Subarachnoid Hemorrhage.经颅多普勒动脉压梯度与蛛网膜下腔出血后延迟性梗死相关。
J Neuroimaging. 2025 Jan-Feb;35(1):e70010. doi: 10.1111/jon.70010.
白细胞介素-4 通过诱导蛛网膜下腔出血后小胶质细胞的表型转化来调节神经炎症。
Inflammation. 2024 Feb;47(1):390-403. doi: 10.1007/s10753-023-01917-z. Epub 2023 Oct 29.
4
Astrocytes Undergo Metabolic Reprogramming in the Multiple Sclerosis Animal Model.星形胶质细胞在多发性硬化症动物模型中经历代谢重编程。
Cells. 2023 Oct 19;12(20):2484. doi: 10.3390/cells12202484.
5
Astrocytes dynamically regulate the blood-brain barrier in the healthy brain.星形胶质细胞在健康大脑中动态调节血脑屏障。
Neural Regen Res. 2024 Apr;19(4):709-710. doi: 10.4103/1673-5374.382248.
6
Neutrophil to Lymphocyte Ratio and Serum Biomarkers : A Potential Tool for Prediction of Clinically Relevant Cerebral Vasospasm after Aneurysmal Subarachnoid Hemorrhage.中性粒细胞与淋巴细胞比值及血清生物标志物:一种预测动脉瘤性蛛网膜下腔出血后临床相关脑血管痉挛的潜在工具。
J Korean Neurosurg Soc. 2023 Nov;66(6):681-689. doi: 10.3340/jkns.2023.0157. Epub 2023 Aug 25.
7
Safety and pharmacodynamic efficacy of eculizumab in aneurysmal subarachnoid hemorrhage (CLASH): A phase 2a randomized clinical trial.依库珠单抗治疗颅内动脉瘤性蛛网膜下腔出血的安全性和药效学疗效(CLASH):一项 2a 期随机临床试验。
Eur Stroke J. 2023 Dec;8(4):1097-1106. doi: 10.1177/23969873231194123. Epub 2023 Aug 22.
8
Glial cell response and microthrombosis in aneurysmal subarachnoid hemorrhage patients: An autopsy study.胶质细胞反应与颅内动脉瘤性蛛网膜下腔出血患者的微血栓形成:一项尸检研究。
J Neuropathol Exp Neurol. 2023 Aug 21;82(9):798-805. doi: 10.1093/jnen/nlad050.
9
Pretreatment with Clodronate Improved Neurological Function by Preventing Reduction of Posthemorrhagic Cerebral Blood Flow in Experimental Subarachnoid Hemorrhage.氯膦酸二钠预处理通过防止实验性蛛网膜下腔出血后脑血流减少改善神经功能。
Neurocrit Care. 2023 Aug;39(1):207-217. doi: 10.1007/s12028-023-01754-w. Epub 2023 Jun 12.
10
Clinical Potential of Immunotherapies in Subarachnoid Hemorrhage Treatment: Mechanistic Dissection of Innate and Adaptive Immune Responses.免疫疗法在蛛网膜下腔出血治疗中的临床潜力:先天免疫和适应性免疫反应的机制剖析
Aging Dis. 2023 Oct 1;14(5):1533-1554. doi: 10.14336/AD.2023.0126.